Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivo
Aviva Geretz1,2, Philip K Ehrenberg1, Robert J Clifford1,2
1U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
Science Translational Medicine
|August 2, 2023
Summary
Prothymosin alpha (PTMA) restricts HIV-1 infection in vivo. This discovery identifies a key host factor for viral control, impacting HIV transmission and potential cure strategies.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- Host restriction factors are crucial for innate antiviral defense against pathogens like HIV-1.
- Identifying specific host factors that control HIV-1 replication in vivo is essential for understanding viral pathogenesis and developing interventions.
Purpose of the Study:
- To identify host factors associated with HIV-1 control during acute infection using single-cell transcriptomic analysis.
- To investigate the role of prothymosin alpha (PTMA) as a potential HIV-1 restriction factor.
Main Methods:
- Single-cell RNA sequencing was employed to correlate host gene expression with intracellular viral RNA levels in infected cells.
- Genome-wide association analysis identified significant inverse correlations between PTMA expression and viral RNA transcription.
- In vitro experiments were conducted to validate the inhibitory effect of PTMA on HIV-1 transcription and production.
Main Results:
- A significant inverse correlation was observed between prothymosin alpha (PTMA) gene expression and intracellular HIV-1 RNA levels.
- This association was validated across diverse patient cohorts with different HIV-1 subtypes (CRF01_AE and subtype B).
- Overexpression of PTMA in vitro demonstrated its ability to inhibit HIV-1 transcription and infectious virus production.
Conclusions:
- Prothymosin alpha (PTMA) is identified as a novel host factor that restricts HIV-1 infection in vivo.
- The findings have significant implications for understanding HIV-1 transmission dynamics.
- This discovery opens new avenues for developing therapeutic strategies targeting PTMA for HIV-1 cure.
More Related Videos
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
15.7K
07:18High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
5.9K
